PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Investment Update - Not Financial Advice
Date: March 27, 2024
Company: PMV Pharmaceuticals
News: PMV Pharmaceuticals has announced the...
PMV Pharmaceuticals opens approximately 94% above IPO price and it is stated that the offering was upsized from 7.4M shares to ~11.8M shares and priced at the high-end of the expected range. What's your opinion in this?